EUVIMEDEUVIMED entdecken
Crossref

Allopregnanolone reduces the blocking properties of competitive antagonists of GABA(A) receptor

Rodion V Kondratenko, Julia V Bukanova, Elena I Solntseva

Neurochemistry International · 2026-10 · 199 · 106219

DOI: 10.1016/j.neuint.2026.106219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemistry International, 2026-10. Verfasst von Rodion V Kondratenko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Russian Center of Neurology and Neurosciences, Moscow, Russia. Hauptthemen laut MEDLINE: Pregnanolone, Receptors, GABA-A, GABA-A Receptor Antagonists. Die Arbeit nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The orthosteric site of the GABAA receptor binds both the agonist (GABA) and the competitive antagonists bicuculline (Bic) and gabazine (GBZ). The endogenous neurosteroid allopregnanolone (Allo) is known to alter the conformation of the orthosteric site of the GABAA receptor, increasing its affinity for GABA. The aim of this study was to investigate the effect of Allo on the blocking properties of Bic and GBZ. Experiments were conducted on isolated rat cerebellar Purkinje cells, in which the GABA-induced chloride current (IGABA) was recorded using the patch-clamp method. The effect of Allo on the blocking properties of Bic and GBZ was studied using two approaches. First, we used functionally equivalent GABA concentrations to induce IGABA in the absence or presence of 1 μM Allo and measured the magnitude of the IGABA block induced by 0.5 μM GBZ or 5 μM Bic. It was shown that, in the presence of Allo, blocking effect was reduced for GBZ from 63 to 31 % (p < 0.05), and for Bic from 87 to 56 % (p < 0.001). The second approach was to study the behavior of dose-effect curve for antagonist (GBZ or Bic) in the presence of Allo. Allo caused the right shift of both dose-effect curves with the increase in the IC50 values from 0.22 to 0.60 μM for GBZ (p < 0.001), and from 1.1 to 2.4 μM for Bic (p < 0.05). Results suggest that Allo decreases the blocking properties of competitive antagonists Bic and GBZ of the GABAA receptor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PregnanoloneReceptors, GABA-AGABA-A Receptor AntagonistsAnimalsBicucullineRatsPyridazinesPatch-Clamp TechniquesGABA AntagonistsRats, WistarBinding, CompetitiveDose-Response Relationship, Drug

Stichwörter der Autor:innen

AllopregnanoloneBicucullineGABA(A) receptorGabazine

Substanzen

PregnanoloneBicucullineReceptors, GABA-AGABA-A Receptor AntagonistsgabazinePyridazinesGABA Antagonists

Autor:innen und Institutionen

  • Russian Center of Neurology and Neurosciences, Moscow, Russia.
  • Russian Center of Neurology and Neurosciences, Moscow, Russia. Electronic address: synaptology@mail.ru.

Zitieren

APA

Kondratenko, R. V., Bukanova, J. V., & Solntseva, E. I. (2026). Allopregnanolone reduces the blocking properties of competitive antagonists of GABA(A) receptor. Neurochemistry International, 199, 106219. https://doi.org/10.1016/j.neuint.2026.106219

Vancouver

Kondratenko RV, Bukanova JV, Solntseva EI. Allopregnanolone reduces the blocking properties of competitive antagonists of GABA(A) receptor. Neurochemistry International. 2026;199:106219. doi:10.1016/j.neuint.2026.106219

BibTeX
@article{Kondratenko2026,
  author = {Kondratenko, Rodion V and Bukanova, Julia V and Solntseva, Elena I},
  title = {Allopregnanolone reduces the blocking properties of competitive antagonists of GABA(A) receptor},
  journal = {Neurochemistry International},
  year = {2026},
  volume = {199},
  pages = {106219},
  doi = {10.1016/j.neuint.2026.106219}
}
Kostenlos starten →